Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A45014 | 26442842 | Liver Int | Response to 'Effect of metabolic components on incident type 2 diabetes mellitus in nonalcoholic fatty liver disease subjects'. | 2016 | Details |
| A45015 | 26436371 | Ann Hepatol | Nonalcoholic fatty liver disease and polycystic ovary syndrome. | 2016 | Details |
| A45016 | 26435214 | Toxicol Appl Pharmacol | Silent information regulator 1 (SIRT1) ameliorates liver fibrosis via promoting activated stellate cell apoptosis and reversion. | 2015 | Details |
| A45017 | 26432016 | Trends Mol Med | Modulation of Glucokinase Regulatory Protein: A Double-Edged Sword? | 2015 | Details |
| A45018 | 26427081 | Zhonghua Gan Zang Bing Za Zhi | [Potential values for diagnosis and assessment of nonalcoholic fatty liver disease staging using Gd+-EOB-DTPA-enhanced MRI]. | 2015 | Details |
| A45019 | 26427074 | Zhonghua Gan Zang Bing Za Zhi | [Obstructive sleep apnea hypopnea syndrome and nonalcoholic fatty liver disease]. | 2015 | Details |
| A45020 | 26426833 | Eur J Gastroenterol Hepatol | Gallstones are associated with hidradenitis suppurativa: a population-based and hospital-based cross-sectional study from Denmark. | 2015 | Details |
| A45021 | 26419525 | Physiol Genomics | Gestation under chronic constant light leads to extensive gene expression changes in the fetal rat liver. | 2015 | Details |
| A45022 | 26416793 | Curr Drug Targets | Editorial: From Multiple Hits to Multiple Therapeutic Targets of Non-Alcoholic Fatty Liver Disease. | 2015 | Details |
| A45023 | 26409177 | Gastroenterology | Liver histology and clinical trials for nonalcoholic steatohepatitis-perspectives from 2 pathologists. | 2015 | Details |
| A45024 | 26405717 | J Gastrointestin Liver Dis | Metabolomics for genomics: the role of vitamin D in nonalcoholic fatty liver disease. | 2015 | Details |
| A45025 | 26396156 | Toxicol Sci | PCB126-Induced Disruption in Gluconeogenesis and Fatty Acid Oxidation Precedes Fatty Liver in Male Rats. | 2015 | Details |
| A45026 | 26392290 | Eat Weight Disord | Prediction of non-alcoholic fatty liver disease by obesity indices. | 2015 | Details |
| A45027 | 26386359 | Liver Int | Heterogeneity of non-alcoholic fatty liver disease. | 2015 | Details |
| A45028 | 26386230 | Liver Int | Effect of metabolic components on incident type 2 diabetes mellitus in non-alcoholic fatty liver disease subjects. | 2015 | Details |
| A45029 | 26382727 | Dig Liver Dis | Comment on "Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: A randomized controlled trial" by Shihui Chen et al. [Dig. Liver Dis. 2015;47:226-32]. | 2015 | Details |
| A45030 | 26380389 | Can J Gastroenterol Hepatol | Role of the NLRP3 inflammasome in the progression of nonalcoholic fatty liver disease to nonalcoholic steatohepatitis. | 2015 | Details |
| A45031 | 26378638 | Semin Liver Dis | Foreword. Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A45032 | 26378385 | Clin Transl Gastroenterol | Isoprene in the Exhaled Breath is a Novel Biomarker for Advanced Fibrosis in Patients with Chronic Liver Disease: A Pilot Study. | 2015 | Details |
| A45033 | 26376348 | Gastroenterology | Physiological Mechanisms of Weight Gain-Induced Steatosis in People With Obesity. | 2015 | Details |
| A45034 | 26374817 | Laeknabladid | [How should obesity be measured in childhood?[Editorial]]. | 2015 | Details |
| A45035 | 26364558 | Dig Liver Dis | Authors' reply to the comment on "Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: A randomized controlled trial" by Shihui Chen et al. [Dig. Liver Dis. 2015;47:226-32]. | 2015 | Details |
| A45036 | 26364406 | Med Monatsschr Pharm | [Nonalcoholic fatty liver disease. Pathophysiologically oriented diagnosis and therapy]. | 2015 | Details |
| A45037 | 26352206 | Biochim Biophys Acta | Nicotinamide ameliorates palmitate-induced ER stress in hepatocytes via cAMP/PKA/CREB pathway-dependent Sirt1 upregulation. | 2015 | Details |
| A45038 | 26348283 | Diagn Interv Imaging | Quantification of hepatic fat: Which reference should be the reference? | 2015 | Details |
| A45039 | 26346354 | Nihon Shokakibyo Gakkai Zasshi | [Alcoholic liver disease and nonalcoholic fatty liver disease]. | 2015 | Details |
| A45040 | 26343211 | J Clin Lipidol | Combined dyslipidemia in childhood. | 2015 | Details |
| A45041 | 26340591 | Hepatology | Human immunodeficiency virus and liver disease: An update. | 2015 | Details |
| A45042 | 26327501 | Eur J Gastroenterol Hepatol | Nonalcoholic fatty liver disease and hemorrhoids. | 2015 | Details |
| A45043 | 26318761 | Pharmacol Res | Similarity between studies of dihydromyricetin and reservatrol for NAFLD. | 2015 | Details |
| A45044 | 26315072 | Chin Med J (Engl) | Obstructive Sleep Apnea Syndrome is Associated with Metabolic Syndrome among Adolescents and Youth in Beijing: data from Beijing Child and Adolescent Metabolic Syndrome Study. | 2015 | Details |
| A45045 | 26308759 | Altern Ther Health Med | Red Yeast Rice Plus Berberine: Practical Strategy for Promoting Vascular and Metabolic Health. | 2015 | Details |
| A45046 | 26302499 | J Clin Gastroenterol | Is Mean Platelet Volume Actually Significantly Higher in Patients With Nonalcoholic Fatty Liver Disease? | 2016 | Details |
| A45047 | 26301251 | Biomed Res Int | Krill Oil Ameliorates Mitochondrial Dysfunctions in Rats Treated with High-Fat Diet. | 2015 | Details |
| A45048 | 26299475 | Pharmacol Res | Response to letter to the Editor: "Similarity between studies of dihydromyricetin and resveratrol for NAFLD". | 2015 | Details |
| A45049 | 26297919 | J Hepatol | Sedentary behaviour, physical activity, and NAFLD: Curse of the chair. | 2015 | Details |
| A45050 | 26294696 | Gut | High-dose vitamin D supplementation and liver histology in NASH. | 2015 | Details |
| A45051 | 26291665 | Clin Gastroenterol Hepatol | Current and Future Burden of Chronic Nonmalignant Liver Disease. | 2015 | Details |
| A45052 | 26290862 | Biomed Res Int | Non-Alcoholic Steatohepatitis: Pathogenesis and Clinical Management. | 2015 | Details |
| A45053 | 26286464 | EBioMedicine | Lysosomal Acid Lipase Activity: A Tool for the Detection and Management of Fatty Liver Disease? | 2015 | Details |
| A45054 | 26278560 | Aliment Pharmacol Ther | Editorial: novel association between serum Pentraxin-2 levels and advanced fibrosis in well-characterised patients with non-alcoholic fatty liver disease--authors' reply. | 2015 | Details |
| A45055 | 26278559 | Aliment Pharmacol Ther | Editorial: novel association between serum Pentraxin-2 levels and advanced fibrosis in well-characterised patients with non-alcoholic fatty liver disease. | 2015 | Details |
| A45056 | 26259497 | Clin Endocrinol (Oxf) | The author's reply: Pancreatic fat and hepato-metabolic features in obese children with nonalcoholic fatty liver disease. | 2015 | Details |
| A45057 | 26249134 | Clin Endocrinol (Oxf) | Pancreatic fat and hepato-metabolic features in obese children with nonalcoholic fatty liver disease. | 2015 | Details |
| A45058 | 26239845 | Nat Rev Gastroenterol Hepatol | NASH: CX3CR1-a direct line to gut-liver crosstalk? | 2015 | Details |
| A45059 | 26238582 | Aliment Pharmacol Ther | Letter: PNPLA3, metabolic syndrome and NAFLD status in obese subjects. | 2015 | Details |
| A45060 | 26238581 | Aliment Pharmacol Ther | Letter: PNPLA3, metabolic syndrome and NAFLD status in obese subjects--authors' reply. | 2015 | Details |
| A45061 | 26238272 | Hepatology | Reply: To PMID 25524401. | 2015 | Details |
| A45062 | 26238083 | Hepatology | Does the death knell toll for phlebotomy in NAFLD? | 2015 | Details |
| A45063 | 26228654 | Liver Transpl | De novo hepatic steatosis drives atherogenic risk in liver transplantation recipients. | 2015 | Details |
| A45064 | 26228371 | Saudi J Gastroenterol | Noninvasive methods to diagnose NAFLD. | 2016 | Details |
| A45065 | 26206676 | Hepatology | Reply. | 2015 | Details |
| A45066 | 26206563 | Hepatology | Sarcopenia and nonalcoholic fatty liver disease: New evidence for low vitamin D status contributing to the link. | 2015 | Details |
| A45067 | 26206460 | Hepatology | The fat droplet in hepatocellular ballooning and implications for scoring nonalcoholic steatohepatitis therapeutic response. | 2015 | Details |
| A45068 | 26194078 | Endocrinol Metab (Seoul) | Exendin-4 Inhibits the Expression of SEPP1 and Fetuin-A via Improvement of Palmitic Acid-Induced Endoplasmic Reticulum Stress by AMPK. | 2014 | Details |
| A45069 | 26187725 | J Formos Med Assoc | Association between serum uric acid and nonalcoholic fatty liver disease. | 2015 | Details |
| A45070 | 26179764 | Aliment Pharmacol Ther | Letter: TNFα inhibitors and prevalence of fatty liver disease in chronic inflammatory diseases. | 2015 | Details |
| A45071 | 26169862 | Lancet | Trials of obeticholic acid for non-alcoholic steatohepatitis. | 2015 | Details |
| A45072 | 26169861 | Lancet | Trials of obeticholic acid for non-alcoholic steatohepatitis - Authors' reply. | 2015 | Details |
| A45073 | 26169860 | Lancet | Trials of obeticholic acid for non-alcoholic steatohepatitis. | 2015 | Details |
| A45074 | 26167698 | Z Gastroenterol | [S2k Guideline non-alcoholic fatty liver disease]. | 2015 | Details |
| A45075 | 26167075 | World J Gastroenterol | Ezetimibe improves hepatic steatosis in relation to autophagy in obese and diabetic rats. | 2015 | Details |
| A45076 | 26167064 | World J Gastroenterol | Liver disease in menopause. | 2015 | Details |
| A45077 | 26162026 | Radiology | Hepatic MR Elastography: Clinical Performance in a Series of 1377 Consecutive Examinations. | 2015 | Details |
| A45078 | 26153994 | Nat Biotechnol | Alexion pays big for Synageva's rare disease drug candidate. | 2015 | Details |
| A45079 | 26149955 | Hepatol Res | Is non-alcoholic fatty liver disease a systemic disease that promotes extrahepatic cancer development? | 2015 | Details |
| A45080 | 26139132 | Cell Stress Chaperones | The detection and role of heat shock protein 70 in various nondisease conditions and disease conditions: a literature review. | 2015 | Details |
| A45081 | 26138960 | Science | The liver's weighty problem. | 2015 | Details |
| A45082 | 26138651 | Dig Dis Sci | Concurrent Obesity, Diabetes, and Steatosis Increase Risk of Advanced Fibrosis Among HCV Patients: A Systematic Review. | 2015 | Details |
| A45083 | 26129791 | Nat Rev Drug Discov | The NASH drug dash. | 2015 | Details |
| A45084 | 26122476 | Nat Rev Gastroenterol Hepatol | NAFLD: Cardiovascular complications of NAFLD--they do matter. | 2015 | Details |
| A45085 | 26122405 | Hepatology | Bile acids and nonalcoholic fatty liver disease: An intriguing relationship. | 2015 | Details |
| A45086 | 26121577 | PLoS One | Correction: Mouse Models of Diet-Induced Nonalcoholic Steatohepatitis Reproduce the Heterogeneity of the Human Disease. | 2015 | Details |
| A45087 | 26116803 | Gastroenterology | Weight Loss for a Healthy Liver. | 2015 | Details |
| A45088 | 26116800 | Gastroenterology | The Hierarchical Model of NAFLD: Prognostic Significance of Histologic Features in NASH. | 2015 | Details |
| A45089 | 26108684 | Mol Nutr Food Res | Calebin-A inhibits adipogenesis and hepatic steatosis in high-fat diet-induced obesity via activation of AMPK signaling. | 2015 | Details |
| A45090 | 26105975 | J Endocrinol Invest | Association between nonalcoholic fatty liver disease and bone mineral density: a systematic review and meta-analysis. | 2015 | Details |
| A45091 | 26103612 | Curr Opin Lipidol | Bariatric surgery, lipoprotein metabolism and cardiovascular risk. | 2015 | Details |
| A45092 | 26100370 | Nat Rev Gastroenterol Hepatol | NAFLD: Sugary drinks and fatty liver--a bitter-sweet relationship. | 2015 | Details |
| A45093 | 26096415 | J Am Geriatr Soc | Astaxanthin Improves Nonalcoholic Fatty Liver Disease in Werner Syndrome with Diabetes Mellitus. | 2015 | Details |
| A45094 | 26093740 | Transplant Proc | Histopathological Examination of Explanted Liver After Transplantation in Patients With Cryptogenic Cirrhosis. | 2015 | Details |
| A45095 | 26092479 | Life Sci | Improvement in the expression of hepatic genes involved in fatty acid metabolism in obese rats supplemented with taurine. | 2015 | Details |
| A45096 | 26087519 | Zhonghua Gan Zang Bing Za Zhi | [Effect of glucagon-like peptide 1 on nonalcoholic fatty liver disease]. | 2015 | Details |
| A45097 | 26087516 | Zhonghua Gan Zang Bing Za Zhi | [Research progress in on-invasive diagnosis of nonalcoholic fatty liver disease]. | 2015 | Details |
| A45098 | 26087059 | Clin Transl Gastroenterol | The Influence of the Gut Microbiome on Obesity, Metabolic Syndrome and Gastrointestinal Disease. | 2015 | Details |
| A45099 | 26085100 | J Biol Chem | Hyperinsulinemia Enhances Hepatic Expression of the Fatty Acid Transporter Cd36 and Provokes Hepatosteatosis and Hepatic Insulin Resistance. | 2015 | Details |
| A45100 | 26084585 | Hepatology | Vascular adhesion protein 1 in nonalcoholic steatohepatitis: a novel biomarker? | 2015 | Details |
| A45101 | 26082141 | Thorax | New insights in the pathophysiology of chronic intermittent hypoxia-induced NASH: the role of gut-liver axis impairment. | 2015 | Details |
| A45102 | 26081686 | Aliment Pharmacol Ther | Editorial: triglycerides in chronic liver disease--a marker of disease progression? | 2015 | Details |
| A45103 | 26079972 | Menopause | Letters to the Editor. | 2015 | Details |
| A45104 | 26079971 | Menopause | Letters to the Editor. | 2015 | Details |
| A45105 | 26078958 | Biomed Res Int | Molecular Mechanisms of NAFLD in Metabolic Syndrome. | 2015 | Details |
| A45106 | 26063689 | Am J Clin Nutr | Retinoid X receptor: the forgotten partner in regulating lipid metabolism? | 2015 | Details |
| A45107 | 26061228 | J Med Food | Ethanol Extract of Persimmon Tree Leaves Improves Blood Circulation and Lipid Metabolism in Rats Fed a High-Fat Diet. | 2015 | Details |
| A45108 | 26054998 | Surg Technol Int | Endoscopic Therapeutic Option for Weight Loss and Control of Type 2 Diabetes: the Duodenal-Jejunal Bypass Liner. | 2015 | Details |
| A45109 | 26045277 | Dig Dis | Nuclear receptor variants in liver disease. | 2015 | Details |
| A45110 | 26040050 | Isr Med Assoc J | Current solutions for obesity-related liver disorders: non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. | 2015 | Details |
| A45111 | 26038995 | Orv Hetil | [Clinical Implications of Inflammation and Immunity in Acute and Chronic Liver Disease: Advances in Diagnosis, Treatment and Clinical Practice. AASLD Liver Meeting, Boston, November 7-11, 2014]. | 2015 | Details |
| A45112 | 26037426 | Natl Med J India | Bariatric surgery: An overview. | 2015 | Details |
| A45113 | 26036988 | J Hepatol | Sugar sweetened beverages and fatty liver disease: Rising concern and call to action. | 2015 | Details |